Boomray
Latest round
- Series A
Last raised
- Sep 2022
Total raised
- $44M
Investors
- 7
About Boomray
Based in Beijing, China, and established in 2020, Boomray is a biopharmaceutical company that focuses on the R&D, production, and clinical application of targeted radionuclide therapy for tumors. Boomray is a joint venture, co-established by Wuxi AppTec Group, and Peking University Sunan Research Institute. And it has an R&D centre in Beijing. Boomray provides targeted radionuclide drugs that diagnose and treat neck tumors, brain tumors, pancreatic tumors, rectal tumors, and prostate tumors. Radiopharmaceuticals consist of radioactive atoms and target molecules destroying cancer cells.
Who invested in Boomray
7 investors across 1 round
See all investors in Boomray
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 1, 2022
Amount
$44M
Investors
Questions about Boomray
Who invested in Boomray?
Boomray has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Boomray raised?
Boomray has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Boomray last raise money?
Boomray's most recent round on record is a Series A, in Sep 2022.
What does Boomray do?
Based in Beijing, China, and established in 2020, Boomray is a biopharmaceutical company that focuses on the R&D, production, and clinical application of targeted radionuclide therapy for tumors.
Where is Boomray headquartered?
Boomray is headquartered in Beijing, China.
Which VCs invest in companies like Boomray?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Boomray's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Boomray? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.